Next, we evaluated the association of CHL1 gene expression with NB patient outcomes, using online microarray data from two independent NB patients data-sets (Versteeg and SEQC) obtained from the R2 Genomics Analysis and Visualization Platform (http://r2.amc.nl). This evidence concerns the gene CHL1 and neuroblastoma.